The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. To learn more about eligibility and participation call 877-789-6100.

Protocol #DescriptionPhase
08-375Phase I/II Study of Neoadjuvant Accelerated Short Course Radiation Therapy with Photons and Capecitabine for Resectable Pancreatic Cancer (View details on clinicaltrial.gov)Phase II
06-248Phase I/II Study of Neoadjuvant Accelerated Short Course Radiation Therapy with Proton Beam and Capecitabine for Resectable Pancreatic Cancer (View details on clinicaltrial.gov)Phase II
09-114Phase I/II Study of Vorinostat in Combination with Radiation Therapy and Infusional 5-FU in Patients with Locally Advanced Adenocarcinoma of the Pancreas (View details on clinicaltrial.gov)Phase II
3 clinical trials listed.
Through our founding membership in the Dana-Farber/Harvard Cancer Center, an NCI-designated Comprehensive Cancer Center, these clinical trials are conducted at the Massachusetts General Hospital Cancer Center and may be available at other partner institutions.